Geodon

   
Google
 
Web NewDrugInformation.com

Geodon


Drug - Geodon
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INTRAMUSCULAR
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ziprasidone Mesylate
Multiple ingredients are in alphabetical order.

Strength - EQ 20MG BASE/ML
The potency of the active ingredient(s), Ziprasidone Mesylate. May repeat for multiple part products.

Applicant - PFIZER
The firm name holding legal responsibility for Geodon. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020919
The FDA assigned number to Geodon. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Geodon. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 21, 2002
The date Geodon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Geodon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Geodon is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Inc
The full name of the firm holding legal responsibility for the new application of Geodon.

Geodon